Synit Drugs Pvt Ltd

Pharmaceutical company specializing in manufacturing, refining, and trading of various chemicals and drugs.

1984 | Mumbai, Maharashtra (India) | Active
Last Updated:

Synit Drugs Profile

Key Indicators

  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 1.66 M
  • Company Age 40 Year, 6 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 43.56%
  • Profit Growth 64.18%
  • Ebitda 76.07%
  • Net Worth 10.39%
  • Total Assets 10.35%

About Synit Drugs

Synit Drugs Pvt Ltd (SDPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 October 1984 and has a history of 40 years and six months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.66 M, as per Ministry of Corporate Affairs (MCA) records.

Pranabh Mody, Sejal Mody, Sharan Asher, and One other member serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230MH1984PTC034255

  • Company No.

    034255

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    12 Oct 1984

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma
Company report

Synit Drugs Pvt Ltd

Explore comprehensive data for Synit Drugs Pvt Ltd, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Synit Drugs?

Board Members (4)

NameDesignationAppointment DateStatus
Pranabh Mody Country flag representing In Director 22-Dec-2020Current
Sejal Mody Country flag representing In Director 02-Nov-2021Current
Sharan Asher Country flag representing In Director 02-Nov-2021Current
Purvi Asher Country flag representing In Director 22-Dec-2020Current

Financial Performance of Synit Drugs.

Synit Drugs Pvt Ltd, for the financial year ended 2017, experienced significant growth in revenue, with a 43.56% increase. The company also saw a substantial improvement in profitability, with a 64.18% increase in profit. The company's net worth Soared by an impressive increase of 10.39%.

Synit Drugs revenue growth over time
Synit Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
43.56%
Revenue from Operations
Total Assets
10.35%
Profit or Loss
64.18%
Net Worth
10.39%
EBITDA
76.07%

What is the Ownership and Shareholding Structure of Synit Drugs?

In 2017, Synit Drugs had a promoter holding of 29.11% and a public holding of 70.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Synit Drugs?

Unlock and access historical data on people associated with Synit Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Synit Drugs Pvt Ltd

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synit Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synit Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Synit Drugs

Recent activity within the organization

  • Annual General Meeting

    Synit Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Synit Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

  • Director Appointment

    Sejal Pranabh Mody was appointed as a Director was appointed as a Director on 02 Nov 2021 & has been associated with this company since 3 years 6 months .

  • Director Appointment

    Sharan Uday Asher was appointed as a Director was appointed as a Director on 02 Nov 2021 & has been associated with this company since 3 years 6 months .

  • Director Appointment

    Pranabh Dinesh Mody was appointed as a Director was appointed as a Director on 22 Dec 2020 & has been associated with this company since 4 years 4 months .

  • Director Appointment

    Purvi Uday Asher was appointed as a Director was appointed as a Director on 22 Dec 2020 & has been associated with this company since 4 years 4 months .

Frequently asked questions

  • What is the Incorporation or founding date of Synit Drugs Pvt Ltd?

    Synit Drugs Pvt Ltd was incorporated on 12 Oct 1984.

  • What is authorized share capital and paid-up capital of Synit Drugs Pvt Ltd?

    The authorized share capital of Synit Drugs Pvt Ltd is ₹ 5.00 M and paid-up capital is ₹ 1.66 M.

  • Who are the current board members & directors of Synit Drugs Pvt Ltd?

    Currently 4 directors are associated with Synit Drugs Pvt Ltd.

    • Pranabh Dinesh Mody
    • Sejal Pranabh Mody
    • Sharan Uday Asher
    • Purvi Uday Asher

  • What is the registered address of Synit Drugs Pvt Ltd?

    As per Ministry of Corporate Affairs (Mca), the registered address of Synit Drugs Pvt Ltd is 804 Floor-8 Plot-3/301 4/401 Lodha Supremus Dr E Moses Road Worli Nakka, Worli India, Mumbai, Maharashtra, 400018.

  • What is the corporate identification number (CIN) and company number of Synit Drugs Pvt Ltd?

    The corporate identification number (CIN) of Synit Drugs Pvt Ltd is U24230MH1984PTC034255 and the company number is 034255 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Synit Drugs Pvt Ltd?

    According to the financial reports for the fiscal year 2017, the revenue trend for Synit Drugs Pvt Ltd has risen by 43.56%.

  • What change has been observed in the net worth of Synit Drugs Pvt Ltd, and by what percentage?

    The financial reports for the fiscal year 2017 indicates that The net worth of Synit Drugs Pvt Ltd has experienced an upsurge of 10.39%.

  • When was the last Balance Sheet of Synit Drugs Pvt Ltd filed with the ROC?

    The most recent Balance Sheet for Synit Drugs Pvt Ltd was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development